What were Mukka Proteins Ltd's latest quarterly results?
Mukka Proteins Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: 0.0%
- Revenue Growth YoY: +115.8%
- Operating Margin: 7.0%
Mukka Proteins Ltd (FMCG Processing - Other) — fundamental analysis, earnings data, and key metrics. PE: 13.3. ROE: 11.1%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on publicly available financial data. This is educational research, not investment advice.
Mukka Proteins Ltd's latest quarterly results (Dec 2025) show
Mukka Proteins Ltd's current PE ratio is 13.3x.
Mukka Proteins Ltd's price-to-book ratio is 1.3x.
Mukka Proteins Ltd's fundamental strength based on key financial ratios
Mukka Proteins Ltd has a debt-to-equity ratio of N/A.
Mukka Proteins Ltd's return ratios over recent years
Mukka Proteins Ltd's operating cash flow is negative (FY2025).
Mukka Proteins Ltd currently does not pay a significant dividend (yield 0.00%).
Mukka Proteins Ltd's shareholding pattern (Dec 2025)
Mukka Proteins Ltd's promoter holding has remained stable recently.
Mukka Proteins Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Based on quantitative research signals, here is why Mukka Proteins Ltd may be worth studying
Mukka Proteins Ltd investment thesis summary:
Mukka Proteins Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.